Skip to main content
. 2022 Feb 4;16(2):e0010152. doi: 10.1371/journal.pntd.0010152

Table 5. Characteristics of the Index tests (n = 72) from the 35 included studies.

Characteristic No. (%)
Analyte
IgM antibodies 48 (66.7)
IgG antibodies 15 (20.8)
Antibodies 2 (2.8)
Antigen 7 (9.7)
Index test
Commercial assay 39 (54.2)
In-house developed assay 33 (45.8)
Index test format
ELISA-based 46 (63.9)
Rapid test 20 (27.8)
Immunofluorescence assay 6 (8.3)
Study design
Cohort 17 (23.6)
Case-control 18 (25)
Partial cohort and partial case-control 37 (51.4)